Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 410 followers
Latest posts
Last updated 2 days ago
Amylyx demystifies post-bariatric hypoglycemia with patient education website
2 days ago
Amylyx’s patient education website aims to empower patients to navigate post-bariatric hypoglycemia...
Daiichi Sankyo flags accounting error, as shares tank despite revenue beat
2 days ago
A Daiichi Sankyo quarterly report that should have celebrated strong commercial execution...
AbbVie's Skyrizi shrugs off new competition as it thrives in growing psoriasis market
2 days ago
Seven years after it was approved, AbbVie's Skyrizi has proven to be...
Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis
2 days ago
Reporting a new miss in one indication, Karyopharm is plowing ahead with...
Psychedelics, peptides and GLP-1s
2 days ago
This week on “The Top Line,” Fierce’s Zoey Becker, Will Maddox and...
Fierce Pharma Asia—Legend CEO exits; Merck’s hush-hush PD-1xVEGF plan; Otsuka’s novel ADHD nod
3 days ago
Legend Biotech's Ying Huang, Ph.D., resigned after a six-year stint as CEO...
Shionogi makes the call on COVID pill Xocova TV spot
3 days ago
Shionogi's “Got the Call, Make the Call” campaign for COVID antiviral Xocova...
Why the Real Risk in Hub Transition is Inertia
3 days ago
Manufacturers often focus on the costs of hub transition. The bigger risk...
Inside Noble’s connected approach to patient support
3 days ago
As self-administered therapies grow, pharma companies are rethinking how onboarding, training and...
Pharma Doesn’t Need Another Walled Garden. Daily Command Was Built to Be the Opposite
3 days ago
In pharma, a wall doesn't just cost money, it stands between a...
Pfizer takes Litfulo to regulators in vitiligo challenge to Incyte, AbbVie
3 days ago
In hopes of challenging Incyte’s topical JAK inhibitor Opzelura, Pfizer is headed...
YouTuber MrBeast welcomes Amgen to the channel, kicking off pediatric cancer funding effort
3 days ago
In MrBeast's new “I Helped 100 Kids Fight Cancer" YouTube video, Amgen...